IBM Watson Health announced that Baheal Pharmaceutical Group will bring Watson for Genomics to clinicians across China. As IBM's primary channel partner for Watson for Genomics in China, Baheal will establish an ecosystem within China to sell the molecular data interpretation technology to clinicians and researchers across the country. The [...]
Tue, Jun 27, 2017, Continue reading at the source
Flagship Pioneering, a fully-integrated life science innovation enterprise, announced the launch of Sigilon Therapeutics. Sigilon Therapeutics is a biopharmaceutical company that discovers and develops category-defining biocompatible encapsulated cell therapies. Sigilon Therapeutics' discovery platform combines cell engineering and revolutionary biocompatible Afibromer technology, a new class of implantable biomaterials that do not [...]
Tue, Jun 27, 2017, Continue reading at the source
Medidata, a global provider of cloud-based technology and data analytics for clinical research, announced results of an industry survey to better understand how global life sciences companies think about and use data in clinical research. Conducted in partnership with PharmaVOICE magazine and titled “Using Data and Analytics in Clinical Development,” [...]
Tue, Jun 27, 2017, Continue reading at the source
ImmunoGen, a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, presented data from the ongoing phase I study evaluating single agent IMGN779 in patients with relapsed or refractory adult acute myeloid leukemia (AML) whose tumors express CD33. The first-in-human data demonstrate the safety and [...]
Tue, Jun 27, 2017, Continue reading at the source
The FDA approved Haegarda, the first C1 Esterase Inhibitor (Human) for subcutaneous (under the skin) administration to prevent Hereditary Angioedema (HAE) attacks in adolescent and adult patients. The subcutaneous route of administration allows for easier at-home self-injection by the patient or caregiver, once proper training is received. HAE, which is [...]
Tue, Jun 27, 2017, Continue reading at the source
Nanotherapeutics, a biologics-focused contract development and manufacturing organization (CDMO), announced that Robert J. Hennessey has been appointed chairman of the board. Commenting on the announcement, Peter H. Khoury, Ph.D., president and chief executive officer of Nanotherapeutics, stated, “We are pleased to welcome Bob as chairman of the board. As a [...]
Tue, Jun 27, 2017, Continue reading at the source
The Board of Directors of the independently associated worldwide Purdue/Napp/Mundipharma network of companies announces that Dr. Craig Landau is appointed president and CEO for the U.S. operations, Purdue Pharma, headquartered in Stamford, Connecticut, with immediate effect, and will retain responsibility for Purdue Pharma (Canada). CEO Mark Timney is leaving Purdue [...]
Tue, Jun 27, 2017, Continue reading at the source
Astellas UK's suspension as a member of the Association of the British Pharmaceutical Industry (ABPI) is to be extended for a further 12 months with effect from June 24 in connection with a number of serious breaches of the ABPI Code. ​​​​Recent cases have shown wholly inadequate oversight and control [...]
Tue, Jun 27, 2017, Continue reading at the source
Compliance Meds Technologies (CMT) announced strategic partnerships with Recovery Centers of America (RCA) and California Highlands to design and implement medication management and communications solutions for use in each providers' MAT programs. CMT is a provider of integrated technology-based solutions focused on improving patient health and reducing the cost of [...]
Mon, Jun 26, 2017, Continue reading at the source
Demand for Clinical Research Associates (CRAs), professionals whose main function is to monitor clinical trials, is expected to grow 1.52% annually by 2018, which results in many sponsors and CROs finding themselves in a never-ending recruitment cycle for qualified CRAs. One of the biggest factors contributing to the global shortage [...]
Mon, Jun 26, 2017, Continue reading at the source